Pre-eclampsia affects between 2-7% of pregnant women. There are conflicting data on plasma 2 homocysteine and folate in pre-eclampsia, and little about fetal concentrations. 3
Introduction 26
Pre-eclampsia is estimated to occur in 2-7% of all pregnancies and is a leading cause of maternal and 27 perinatal mortality and morbidity in the Western world [1] ; together with other hypertensive disorders 28 of pregnancy it is responsible for approximately 60,000 deaths each year [2] . Pre-eclampsia is now 29 commonly regarded as being a state of oxidative stress [3] . It is thought that primarily inadequate 30 placental perfusion results in excessive production of reactive oxygen species giving rise to endothelial 31 cell dysfunction and thus clinical manifestations of pre-eclampsia [4] . 32
Homocysteine is a metabolic product of methyl-group donation by the amino acid methionine; 33 remethylation is catalysed by folate. Small increases in plasma homocysteine concentrations are 34 associated with increased risk of vascular disease [5], Alzheimer's disease [6] and neural tube defects 35 [7] in the general population. Elevated homocysteine concentrations contribute to oxidative stress and 36 endothelial dysfunction [8] and are thus also potentially implicated in the pathogenesis of pre-37 eclampsia. Some studies report raised homocysteine concentrations in pre-eclampsia (e.g. [9, 10] ) 38 while others have shown no significant differences [11, 12] . Maternal and fetal plasma homocysteine 39 concentrations have been reported to be directly correlated in healthy nulliparae [13] and do not appear 40 to change significantly during the course of pregnancy [14] . If plasma homocysteine concentrations are 41 indeed raised in pre-eclampsia, and there is similar parallelism, then the fetus will be exposed to 42 potentially damaging levels of homocysteine even before birth, which might have long-term 43 consequences. Important factors influencing homocysteine concentrations are folate and vitamin B12 44 status and the methylenetetrahydrofolate reductase (MTHFR) polymorphisms [15] ; once again the data 45 on these in pre-eclampsia is conflicting [16, 17] . 46
There is considerably less, but similarly conflicting, evidence linking folate concentrations and pre-47 eclampsia [18, 19] . The fetus must receive an adequate supply of folate for growth and development; 48 inadequate concentrations will also, inter alia, impede the remethylation of homocysteine. Both 49 metabolites have active transport systems in the placenta [20] and impaired placentation is believed to 50 be central to the pathogenesis of pre-eclampsia. Folate has recently been shown to possibly play a 51 direct role in extravillous trophoblast invasion [21] , thus highlighting the need for adequate folate 52 concentrations pre-pregnancy and during the early stages of pregnancy. Studies linking homocysteine 53 and folate in the mother and fetus are very limited [17] . We therefore felt it to be important to measure 54 fetal, as well as maternal, concentrations of homocysteine and folate at delivery. 55
Folate intake among women of reproductive age in the UK is reported to be low [22] . There is an 56 increased demand for folate during pregnancy, which can result in suboptimal folate status [23] , 57 although there is some evidence to suggest that folate turnover during pregnancy does not appear to 58 change if folate intake is adequate [24] . Increasing parity has been associated with decreasing plasma 59 folate concentrations [25, 26] , presumably because lactation is a further drain on folate reserves [27] . If 60 dietary intake is suboptimal, these stores may not be replenished before a subsequent pregnancy, 61 especially in cases of short inter-pregnancy intervals [25, 28] . We are unaware of any studies relating 62 these low folate levels to increased plasma homocysteine concentrations in either parous women as a 63 group, or parous women who develop pre-eclampsia. However, there is indirect evidence for an 64 interaction between parity and raised plasma homocysteine concentrations which has been related to 65 increased risk of pre-eclampsia [29, 30] . We hypothesised that plasma folate concentrations would be 66 lower, and homocysteine higher, in pre-eclamptic women and their babies than in normotensive 67 pregnant controls. We also opportunistically examined the effect of parity on maternal plasma folate 68 concentrations in normal and pre-eclamptic pregnancy. rhamnosus (L. rhamnosus) was used to assess the plasma folate concentrations as described previously 98
[33]; 15 mg/ml manganese sulphate was added to the buffer to avoid artificially low plasma folate 99 values [33, 34] . The inter-and intra-assay CVs were 5% and 4% respectively. 100 having infants weighing > 2500 g, delivered at 37 weeks' gestation or later. The systolic and diastolic 129 blood pressure levels were, by definition, significantly raised in pre-eclampsia compared to normal 130 pregnancy (P < 0.0001 for both; Table 1 ). Overall, the pre-eclamptic women all had moderate-to-131 severe disease (see [31] ). 132
Biochemical and molecular measurements: Maternal and fetal plasma homocysteine and folate 133 concentrations are given in Table 1 . Plasma homocysteine concentrations were very similar in 134 normotensive and pre-eclamptic women; fetal concentrations were also very similar in the two groups. 135
Maternal and fetal homocysteine concentrations were significantly positively correlated (r = 0.68, R 2 = 136 0.68, P < 0.0001). Fetal homocysteine concentrations were higher than maternal in normotensive (P = 137 0.002), but not pre-eclamptic (P > 0.1) pregnancy. 138
Maternal folate appeared higher in normal than pre-eclamptic pregnancy, but there this was not 139 statistically significant due to the large range of data. Fetal plasma folate concentration did not differ 140 across groups (Table 1) Kruskal-Wallis test showed that maternal folate concentrations were significantly different (P = 0.006) 155 between nulliparous women and women who had had one or two previous pregnancies. Subsequent 156
Mann-Whitney U tests indicated that the maternal folate concentrations were significantly higher in 157 nulliparous women compared to parous women with 1 (P = 0.005) and 2 previous (P = 0.037) 158 pregnancies ( other European studies in which no association was found with respect to homocysteine or folate 169 concentrations and normotensive and pre-eclamptic pregnancies [11, 12] . Homocysteine has been 170 potentially linked to processes such as inflammation [35] and hypercoagulation [8] , which are present 171 in severe pre-eclampsia. However, this does not mean that hyperhomocysteinaemia is a requirement for 172 the development of pre-eclampsia and the elevated homocysteine concentrations seen in some pre-173 eclamptic patients may be an associated, or pre-disposing, rather than a causal factor. 174
Folate plays an essential role in the growth of the placenta from early pregnancy; folate deficiency has 175 been linked to placental abruption and thus restricted fetal growth [36] . We observed no significant 176 differences between maternal or fetal samples from normotensive pregnancy or pre-eclampsia. Most 177 folate concentrations were within the reference range (7 -46 nmol/L [37]) for non-pregnant UK adults, 178 using this methodology, but 9 normotensive pregnant (7 parous) and 12 pre-eclamptic (6 parous) 179 women had concentrations below this level and the pre-eclamptic patients had the lowest median 180 values, which is consistent with previous studies examining folate concentrations [10, 17, 38] 
group of normotensive, non-pregnant women of comparable age had a median folate concentration of 189 13.9 nmol/L, relatively low in the reference range [37] . Periconceptual dietary supplementation with 190 folic acid is widely advocated for the prevention of neural tube defects. However, only four women in 191 normotensive and two women in the pre-eclamptic group (Table 1) Although sample sizes were small, we observed lower plasma folate concentrations in parous mothers 195
and their babies in our study (Fig 1a) , a trend exacerbated when pre-eclampsia supervened (Fig 1b) . We 196 do not know whether the parous women began pregnancy with lower stores or whether the uptake or 197 renal reabsorption of folate differs in parous women. Larger studies are required to investigate this 198 further especially by the findings from our group to indicate that folate may be essential early in 199 pregnancy possibly directly promoting extravillous trophoblast invasion [21] . As only two women had 
